NHI delivered solid Q4 2025 results with total revenues of 105823000 and net income attributable to common stockholders of 38113000. Normalized FFO per diluted share increased year-over-year to 1.22, while SHOP NOI more than doubled compared to the prior year period.

National Health Investors, Inc. reported a net income of $33.817 million for Q1 2025, an increase from $30.657 million in Q1 2024. Total revenues grew to $89.296 million from $81.513 million in the prior year, primarily due to new investments and increased occupancy in the SHOP segment. EPS increased to $0.75 basic and $0.74 diluted.

National Health Investors, Inc. (NHI) announced robust financial results for the fourth quarter of 2024, with net income attributable to common stockholders per diluted common share increasing to $0.95 from $0.74 in the prior year. The company's rental income saw an 8.3% increase, primarily due to new investments, and its Senior Housing Operating Portfolio (SHOP) segment experienced a 12.5% growth in net operating income.

National Health Investors, Inc. (NHI) reported its Q3 2024 results, with a net income attributable to common stockholders of $0.65 per diluted share. The company is updating its 2024 annual guidance range. Fundamentals remain strong across much of the portfolio with occupancy and EBITDARM coverage improving sequentially from the second quarter across our major asset classes.

National Health Investors, Inc. (NHI) announced its Q2 2024 results, with net income per diluted share at $0.81, NAREIT FFO per diluted share at $1.18, and Normalized FFO per diluted share also at $1.18. The company is raising its full-year guidance based on strong quarterly results and visibility into the second half of the year.

National Health Investors (NHI) reported a strong start to 2024, exceeding expectations in the first quarter. Key drivers included deferral repayments, revenue growth at NHC, stable rent concessions, and increased SHOP NOI. The company is raising its full-year guidance as a result.

National Health Investors, Inc. (NHI) reported positive Q4 2023 results, with net income attributable to common stockholders at $0.74 per diluted share, compared to $0.04 in the same period last year. The results were driven by deferral repayments and growth in SHOP NOI. The company's financial profile remains strong, with leverage at 4.4 times net debt-to-adjusted EBITDA.

National Health Investors (NHI) reported strong third-quarter results, exceeding expectations due to robust rent collections, significant deferral repayments, discrete payments from cash-basis accounting tenants, and no unexpected rent concessions. EBITDARM coverage ratios improved across all asset classes, and SHOP NOI margins expanded due to occupancy growth.

National Health Investors, Inc. reported second quarter 2023 results with net income per diluted share of $0.92, NAREIT FFO per diluted share of $1.05, and Normalized FFO per diluted share of $1.06. The company revised its 2023 annual guidance for Normalized FFO per share to $4.31 - $4.35 and Normalized FAD to $185.0 million - $186.8 million.

National Health Investors (NHI) reported a strong first quarter in 2023, with net income attributable to common stockholders at $0.79 per diluted share, up from $0.18 in the prior year. NAREIT FFO per diluted share increased to $1.16 from $1.05, and Normalized FFO per diluted share was $1.11, slightly up from $1.10. The company is revising its 2023 annual guidance upwards for Normalized FFO per share and Normalized FAD.

National Health Investors (NHI) reported a net income attributable to common stockholders per diluted common share of $0.04 for Q4 2022, a decrease compared to $0.14 in the same period of the prior year. Normalized FFO per diluted common share was $0.85, including a credit loss reserve of $8.7 million. The company made strategic investments and dispositions, including acquiring an assisted living facility from Bickford Senior Living and funding a senior loan to refinance skilled nursing facilities.

National Health Investors reported a positive third quarter, exceeding expectations due to stronger collections and strategic portfolio optimization. The company completed significant asset dispositions and share repurchases, while navigating a challenging operating environment with elevated labor costs.

National Health Investors, Inc. reported second quarter results with net income attributable to common stockholders per diluted common share at $0.47. The company completed disposition of 10 underperforming senior housing properties and repurchased approximately 1.2 million shares. They reduced debt by approximately $145.0 million and reported net debt to Adjusted EBITDA of 4.0x.

National Health Investors, Inc. reported first quarter 2022 results, featuring a net income attributable to common stockholders of $0.18 per diluted common share, NAREIT FFO per diluted common share of $1.05, and Normalized FFO per diluted common share of $1.10. The company sold two properties for approximately $13.7 million and is making progress on portfolio optimization.

National Health Investors reported a net income of $0.14 per diluted common share for Q4 2021, a decrease compared to $0.83 in the prior year period. The company is actively optimizing its portfolio through dispositions, rent restructuring and tenant transitions.

National Health Investors, Inc. reported a net income attributable to common stockholders per diluted common share of $0.67 for the three months ended September 30, 2021. Normalized FAD was $51.2 million, and Normalized FFO per diluted common share was $1.15.

National Health Investors, Inc. reported a net income of $39.183 million, or $0.85 per diluted share, for the quarter ended June 30, 2021. The results were negatively impacted by higher levels of deferrals. The company has made progress on transforming NHI into a stronger healthcare REIT.

National Health Investors reported a decrease in net income per share for the three months ended March 31, 2021, compared to the same period in the prior year. However, normalized FAD was flat compared to the same period in the prior year and increased compared to the fourth quarter of 2020. The company collected 94.3% of contractual cash due for the quarter.

National Health Investors (NHI) reported a decrease in net income per share for Q4 2020 compared to the same period in the prior year. The company's normalized FFO per share also decreased slightly, while normalized AFFO per share remained unchanged. Despite challenges posed by the COVID-19 pandemic, NHI highlighted its strong collection rates and investments made during the year.

National Health Investors, Inc. reported net income attributable to common stockholders per diluted common share of $0.95 for the three months ended September 30, 2020, a decrease of 2.1% from the same period in the prior year. Normalized FFO per diluted common share was $1.42, unchanged from the same period in the prior year. Normalized AFFO per diluted common share was $1.34, an increase of 1.5% over the same period in the prior year.

National Health Investors, Inc. reported a net income of $0.99 per diluted share and AFFO of $1.35 per diluted share for the second quarter of 2020. The company completed $192.4 million in real estate and mortgage note investments and maintained a low leverage balance sheet.

National Health Investors, Inc. reported a strong first quarter with net income attributable to common stockholders at $1.37 per diluted common share and AFFO at $1.29 per diluted common share. The company announced or completed $173.2 million in real estate and mortgage note investments and maintained a low leverage balance sheet.

National Health Investors reported a net income of $0.95 per diluted common share for Q4 2019, a 9.2% increase year-over-year, and AFFO of $1.30 per diluted common share, a 2.4% increase year-over-year.